Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Chien-Te Tseng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Self-Masked Aldehyde Inhibitors of Cysteine Proteas 3CL Protease, Cathepsin L and Cruzain
Tseng, C.-T. (PI)
11/4/21 → 10/31/24
Project: Research project
-
Evaluate Therapeutic Efficacies of a Monoclonal Antibody against SARS-CoV-2 Infection in Permissive Human ACE2 Transgenic Mice
Tseng, C.-T. (PI)
2/23/21 → 12/31/24
Project: Research project
-
-
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Westberg, M., Su, Y., Zou, X., Huang, P., Rustagi, A., Garhyan, J., Patel, P. B., Fernandez, D., Wu, Y., Hao, C., Lo, C. W., Karim, M., Ning, L., Beck, A., Saenkham-Huntsinger, P., Tat, V., Drelich, A., Peng, B. H., Einav, S. & Tseng, C. T. K. & 2 others, , Mar 13 2024, In: Science Translational Medicine. 16, 738, p. eadi0979 eadi0979.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection
Drelich, A. K., Rayavara, K., Hsu, J., Saenkham-Huntsinger, P., Judy, B. M., Tat, V., Ksiazek, T. G., Peng, B. & Tseng, C. T. K., Jun 2024, In: PLoS pathogens. 20, 6 June, p. e1011777 e1011777.Research output: Contribution to journal › Article › peer-review
Open Access -
Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection
Song, I. W., Washington, M., Leynes, C., Hsu, J., Rayavara, K., Bae, Y., Haelterman, N., Chen, Y., Jiang, M. M., Drelich, A., Tat, V., Lanza, D. G., Lorenzo, I., Heaney, J. D., Tseng, C. T. K., Lee, B. & Marom, R., 2024, (Accepted/In press) In: Mammalian Genome.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Carter, B., Huang, P., Liu, G., Liang, Y., Lin, P. J. C., Peng, B., McKay, L. G. A., Dimitrakakis, A., Hsu, J., Tat, V., Saenkham-Huntsinger, P., Chen, J., Kaseke, C., Gaiha, G. D., Xu, Q., Griffiths, A., Tam, Y. K., Tseng, C. T. K. & Gifford, D. K., Mar 8 2023, In: Frontiers in immunology. 14, p. 1135815 1135815.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Circulating Reelin promotes inflammation and modulates disease activity in acute and long COVID-19 cases
Calvier, L., Drelich, A., Hsu, J., Tseng, C. T., Mina, Y., Nath, A., Kounnas, M. Z. & Herz, J., Jun 25 2023, In: Frontiers in immunology. 14, p. 1185748 1185748.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations